Apixaban vs warfarin: rise of newer anticoagulant
Druggist
APRIL 29, 2021
Eliquis is still protected by patent rights in the UK, with exclusive availability rights until 2026 (IPO, 2021). . Additionally, the dosage is much simpler as compared to warfarin as it does not change generally after treatment initiation is completed. . Patients who have cancer or receive chemotherapy.
98 
Let's personalize your content